RNS Number : 0238Z Renalytix PLC 11 May 2023     Renalytix plc    ("Renalytix" or the "Company")   Notice of General Meeting and Posting of Circular   LONDON and SALT LAKE CITY , May 11, 2023 - Renalytix (NASDAQ: RNLX) (LSE: RENX) announces that a circular containing a notice convening a General

RNS Number : 6476W Renalytix PLC 19 April 2023     Renalytix plc    ("Renalytix" or the "Company")   New Published Real-World Evidence Shows KidneyIntelX™ Utility   Real-World Utility Data Demonstrates KidneyIntelX Optimizes Clinical Management in Early-Stage Chronic Kidney Disease Across Multiple

RNS Number : 8895V Renalytix PLC 12 April 2023   Renalytix plc    ("Renalytix" or the "Company")   Data Supportive of KidneyIntelX Utility in Minorities and Veterans to Be Presented at the National Kidney Foundation Spring Clinical Meeting   In a clinical decision effectiveness study, KidneyIntelX

RNS Number : 7000U Renalytix PLC 30 March 2023       Renalytix plc ("Renalytix" or the "Company")   Half Year Report   LONDON and SALT LAKE CITY , March 30, 2023   -   Renalytix plc (NASDAQ: RNLX) (LSE: RENX), reports its financial results for the six months ended December 31, 2022.

RNS Number : 3435U Renalytix PLC 27 March 2023     The following amendment has been made to the 'Business Update'   announcement released today, 27 March 2023 at 0700 under RNS No 2296U.   The real-world evidence data published in the   Journal of Primary Care Community Health   was published in

RNS Number : 2296U Renalytix PLC 27 March 2023   Renalytix plc    ("Renalytix" or the "Company")   Business Update   LONDON and SALT LAKE CITY , March 27, 2023 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) provides the following business update.   Renalytix has further expanded its insurance coverage

RNS Number : 7566T Renalytix PLC 22 March 2023       Renalytix plc    ("Renalytix" or the "Company")   Renalytix to Report Second Quarter and First Half Fiscal Year 2023 Financial Results on March 30   LONDON and SALT LAKE CITY , March 22, 2023 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today

RNS Number : 7502T Renalytix PLC 21 March 2023   Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this

RNS Number : 7492T Renalytix PLC 21 March 2023   Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered

RNS Number : 5994T Renalytix PLC 21 March 2023     Renalytix plc    ("Renalytix" or the "Company")   Update on FDA De Novo Marketing Authorization Process   LONDON and SALT LAKE CITY , March 21, 2023 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that the review process with the Food and